Acura Pharmaceuticals Stock Price and Value Analysis

Should you buy Acura Pharmaceuticals stock? (Other OTC:ACUR). Let's see how it does in our automated value investing analysis system.

ACUR Free Cash Flow Trend

Free Cash Flow trendline for ACUR
Free Cash Flow trendline for Acura Pharmaceuticals

Hmm, we can't give any reliable projection for Acura Pharmaceuticals's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

  • This company is solid.
  • This stock looks overpriced.
  • This company is not making money.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the ACUR Numbers

ACUR Price
(Acura Pharmaceuticals stock price per share)
[?] PE Ratio versus Sector 59% lower than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Drug Manufacturers - Specialty & Generic stocks
[?] Cash Yield -76.28%
[?] Free Cash Flow Jitter 1995%

Is Acura Pharmaceuticals Stock on Sale?

Based on our analysis, we believe that you should not buy Acura Pharmaceuticals right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy ACUR Stock?

Does Acura Pharmaceuticals have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.